Suchergebnisse - "Weinreich, David M"

PubPharm (21)

1

Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles

enthalten in: Scientific reports | 2023

von Li, D. | Xu, M. | Hooper, A. | +9

2

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period : a randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Herman, G. | O'Brien, M. | Forleo-Neto, E. | +127

CommentIn: Lancet Infect Dis. 2022 Oct;22(10):1400-1401. - PMID 35803288

3

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Isa, F. | Forleo-Neto, E. | Meyer, J. | +28

4

Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Stein, D. | Oviedo-Orta, E. | Kampman, W. | +8

5

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019 : A Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

6

Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection : A Phase 2 Dose-Ranging Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Portal-Celhay, C. | Forleo-Neto, E. | Eagan, W. | +127

7

Survival with Cemiplimab in Recurrent Cervical Cancer

enthalten in: The New England journal of medicine | 2022

von Tewari, K. | Monk, B. | Vergote, I. | +133

CommentIn: Nat Rev Clin Oncol. 2022 Apr;19(4):220. - PMID 35217780

8

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection : A Randomized Clinical Trial

enthalten in: JAMA | 2022

von O'Brien, M. | Forleo-Neto, E. | Sarkar, N. | +136

UpdateOf: medRxiv. 2021 Sep 18;:. - PMID 34159343

9

Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)

enthalten in: Respiratory medicine | 2022

von Bateman, E. | Khan, A. | Xu, Y. | +8

CommentOn: Respir Med. 2022 Jan;191:105991. - PMID 35090688

10

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

enthalten in: The New England journal of medicine | 2021

von Bacharier, L. | Maspero, J. | Katelaris, C. | +123

CommentIn: N Engl J Med. 2021 Dec 9;385(24):2297-2298. - PMID 34879454